LINCOLN PARK CAPITAL FUND
Lincoln Park Capital Fund is a Chicago-based asset management firm focused on opportunistic investing in public and private companies.
LINCOLN PARK CAPITAL FUND
Founded:
2010-01-01
Status:
Active
Contact:
(312) 822-9300
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps GoDaddy DNS Google Google Cloud Comcast
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-03 | Kintara Therapeutics | Lincoln Park Capital Fund investment in Post-IPO Equity - Kintara Therapeutics | 20 M USD |
| 2022-06-07 | Evaxion Biotech | Lincoln Park Capital Fund investment in Post-IPO Equity - Evaxion Biotech | 40 M USD |
| 2022-04-13 | Aquestive Therapeutics | Lincoln Park Capital Fund investment in Post-IPO Equity - Aquestive Therapeutics | 40 M USD |
| 2022-03-07 | Biodesix | Lincoln Park Capital Fund investment in Post-IPO Equity - Biodesix | 50 M USD |
| 2021-11-30 | Gridiron BioNutrients | Lincoln Park Capital Fund investment in Post-IPO Equity - Gridiron BioNutrients | 4 M USD |
| 2021-06-08 | Ocuphire Pharma | Lincoln Park Capital Fund investment in Post-IPO Equity - Ocuphire Pharma | 15 M USD |
| 2021-06-04 | Cyclerion Therapeutics | Lincoln Park Capital Fund investment in Post-IPO Equity - Cyclerion Therapeutics | 18 M USD |
| 2021-03-19 | X4 Pharmaceuticals | Lincoln Park Capital Fund investment in Post-IPO Equity - X4 Pharmaceuticals | 55 M USD |
| 2021-01-07 | Onconova Therapeutics | Lincoln Park Capital Fund investment in Post-IPO Equity - Onconova Therapeutics | 8.7 M USD |
| 2021-01-06 | Aileron Therapeutics | Lincoln Park Capital Fund investment in Post-IPO Secondary - Aileron Therapeutics | 35.9 M USD |